CYTEK BIOSCIENCES INC

Cytek Biosciences Reports Third Quarter 2024 Financial Results

05 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

30 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18 Sep 2024 17:00:00 By Nasdaq GlobeNewswire

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12 Sep 2024 15:20:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

21 Aug 2024 17:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

08 Aug 2024 16:05:01 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Second Quarter 2024 Financial Results

06 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

30 Jul 2024 17:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

30 Jul 2024 16:05:00 By Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

06 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

30 May 2024 16:05:03 By Nasdaq GlobeNewswire

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

28 May 2024 17:30:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

20 May 2024 17:30:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports First Quarter 2024 Financial Results

08 May 2024 16:05:53 By Nasdaq GlobeNewswire

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

30 Apr 2024 17:30:00 By Nasdaq GlobeNewswire

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

29 Apr 2024 09:00:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Names William McCombe Chief Financial Officer

19 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

07 Mar 2024 17:30:00 By Nasdaq GlobeNewswire

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

28 Feb 2024 17:05:36 By Nasdaq GlobeNewswire